Results
|
|
1.
|
|
|
|
2.
|
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. MedStar authors:
Year: 2017
Citation: - Lancet Oncology. 18(11):1493-1501, 2017 Nov
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Attia S, Baker LH, Bolejack V, Burgess M, Butterfield LH, Crowley J, D'Angelo S, Davis LE, Hu J, Lazar AJ, Maki RG, Movva S, Okuno SH, Patel S, Priebat DA, Reed DR, Reinke D, Riedel RF, Rodriguez-Canales J, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wistuba II
|
|
|
3.
|
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC. MedStar authors:
- Atkins, Michael
- Fishbein, Thomas M
- Satoskar, Rohit
Year: 2016
Citation: - Cancer Immunology Research. 4(5):419-30, 2016 May
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department:
- Georgetown Transplant Institute
- Surgery/Transplantation
Medline publication type:
All authors: - Atkins M, Banovac F, Feng P, Fishbein T, Gabrielson A, Gatalica Z, He AR, Island E, Jha R, Jiang J, Johnson L, Kachhela J, Kallakury B, Kleiner D, Loffredo C, Marshall J, Prins P, Reddy S, Satoskar R, Tesfaye A, Wang H, Weiner L, Wu Y, Zhang T
|
